Newest Titles

• Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)
  Article (Journal), Online Resource
• Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial
  Article (Journal), Online Resource
• Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial
  Article (Journal), Online Resource
• Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing
  Article (Journal), Online Resource
• Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
  Article (Journal), Online Resource

see all (7)

Related Authors

• Bozorgmehr, Farastuk
• Christopoulos, Petros
• Thomas, Michael
• Chung, Inn
• Schneider, Marc

see all (78)

Publication Timeline

Publication Formats